Article

Patient-Reported Outcomes of Upadacitinib Versus Abatacept in Patients with Rheumatoid Arthritis and an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: 12-Week Results of a Phase 3 Trial

2021-08-09

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> In previous clinical trials, patients with active rheumatoid arthritis (RA) treated with upadacitinib (UPA) have improved patient-reported outcomes (PROs). This <italic>post hoc</italic> analysis of SELECT-CHOICE, a phase 3, double-blind, randomized clinical trial evaluated the impact of UPA vs abatacept (ABA) with background conventional synthetic disease-modify...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 809b993b-a382-562c-915d-9533e4ec067f
DOI: 10.21203/rs.3.rs-734225/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Patient-Reported Outcomes of Upadacitinib Versus Abatacept in Patients with Rheumatoid Arthritis and an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: 12-Week Results of a Phase 3 TrialDOI 10.21203/rs.3.rs-734225/v1Read

Differences and Similarities in Clinical and Functional Responses Among Patients Receiving Tofacitinib Monotherapy, Tofacitinib Plus Methotrexate, and Adalimumab Plus Methotrexate: A Post-hoc Analysis of Data From Oral StrategySemantic proximity Read

Upadacitinib: Mechanism of action, clinical, and translational scienceSemantic proximity Read

Frontiers in Rheumatoid Arthritis: Emerging Research and Unmet Needs in Pharmacologic ManagementSemantic proximity Read

Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registriesSemantic proximity Read

Effectiveness and Safety of Intravenous Golimumab With and Without Concomitant Methotrexate in Patients With Rheumatoid Arthritis in the Prospective, Noninterventional AWARE StudySemantic proximity Read

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 TreatmentSemantic proximity Read

Real-World Evidence of the Effectiveness and Safety of Generic Tofacitinib in Rheumatoid Arthritis Patients: A Retrospective, Single-Centre Analysis from Western IndiaSemantic proximity Read

Modern Pharmacologic Management of Rheumatoid Arthritis: From Methotrexate to Targeted TherapiesSemantic proximity Read

Monocyte-derived transcriptomes explain the ineffectiveness of abatacept in rheumatoid arthritisSemantic proximity Read

Methotrexate for the treatment of osteoarthritis: a systematic review and meta-analysis of randomized controlled trialsSemantic proximity Read

The impact of different (rheumatoid) arthritis phenotypes on patients' lives.Semantic proximity Read

Add-on Iguratimod or Tacrolimus in Methotrexate Inadequate Rheumatoid Arthritis: Efficacy, Safety and Propensity Score-Matched AnalysisSemantic proximity Read